Goldman Sachs Group Inc Compugen LTD Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
A detailed history of Goldman Sachs Group Inc transactions in Compugen LTD stock. As of the latest transaction made, Goldman Sachs Group Inc holds 346,985 shares of CGEN stock, worth $523,947. This represents 0.0% of its overall portfolio holdings.
Number of Shares
346,985
Previous 483,927
28.3%
Holding current value
$523,947
Previous $812,000
22.66%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding CGEN
# of Institutions
73Shares Held
13.1MCall Options Held
79.2KPut Options Held
12.7K-
Silverarc Capital Management, LLC1.5MShares$2.27 Million0.68% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.29MShares$1.94 Million0.0% of portfolio
-
Taylor Frigon Capital Management LLC1.2MShares$1.81 Million1.09% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.09MShares$1.65 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C31.02MShares$1.54 Million0.0% of portfolio
About COMPUGEN LTD
- Ticker CGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,600
- Market Cap $131M
- Description
- Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...